CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06146569
NCT06146569N/ACompleted

Effects of Transcutaneous Vagus Nerve Stimulation (taVNS) in Individuals With Primary Dysmenorrhea: A Randomized Controlled Study

Artvin Coruh University·interventional·Posted Nov 24, 2023·Updated Oct 29, 2024

In Brief

A clinical study evaluating Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Sham Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Dysmenorrhea Primary and Pain. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study aims to investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on pain, functional and emotional symptoms, and physical performance in individuals with primary dysmenorrhea (PD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 24, 2023
Enrollment StartNov 15, 2023
Primary CompletionJan 15, 2024
Study CompletionJan 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.6 years ago

Interventions

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)device

Current will be applied bilaterally from the tragus and turbinate parts of the ear with the VagustimTM device. The current frequency to be used in modulation mode is 10 Hz, and the pulse width is 300 μs (In modulation mode, the pulse rate and width are automatically changed in a loop pattern. The pulse width is reduced by 50% from its original setting in 0.5 seconds; then, the pulse rate is changed in 0.5 seconds, reduced by 50% from the original setting. Total cycle time is 1 second.). The current intensity will be applied for 5 minutes, keeping the current constant where the participant feels comfortable.

Sham Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)device

For 5 minutes, sham applications will be applied using a current-free headset specifically designed for this purpose. Participants will observe the device's functionality, but it will not supply any current.